Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIMI Regulatory News (IMI)

Share Price Information for IMI (IMI)

Share Price is delayed by 15 minutes
Get Live Data
2,814.00    -14.00 (-0.50%)
Bid:
2,808.00
Ask:
2,810.00
Spread: 2.00 (0.071%)
Market Cap: £6.70b
IMI Live PriceLast checked at - London Stock Exchange

Intraday IMI Share Chart

Share repurchase programme

26 Apr 2021 11:23

RNS Number : 6001W
IMI PLC
26 April 2021
 

26 April 2021

IMI plc

LEI: 2138002W9Q21PF751R30

Share repurchase programme

IMI plc (the Company) announces that, in connection with the 12 month share buyback programme of up to £200 million which it announced on 26 April 2021, it is commencing a share buyback programme (the Programme) to purchase shares with a value of up to £100 million subject to remaining within the AGM authority (the 2020 AGM authority is for a maximum of 27,200,000 shares) during the period starting on 26 April 2021 and ending no later than 4 August 2021 (the Engagement Period) in order to reduce the capital of the Company. Shares purchased pursuant to the Programme will be cancelled. The Company has entered into an agreement with J.P. Morgan Securities plc (JPMS plc) under which it has issued an irrevocable instruction to JPMS plc to manage the share buyback programme. JPMS plc will carry out the instruction through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. This arrangement is in accordance with Chapter 12 of the FCA's Listing Rules and the Company's general authority to repurchase shares. The Programme will also be effected within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (in each case, as in force in the UK from time to time as retained EU law (as defined in the European Union (Withdrawal) Act 2018 as amended from time to time), including where relevant pursuant to the Market Abuse (Amendment)(EU Exit) Regulations 2019). JPMS plc may undertake transactions in shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the Engagement Period in order to manage its market exposure under the Programme. Disclosure of such transactions will not be made by JPMS plc as a result of or as part of the Programme, but JPMS plc will continue to make any disclosures it is otherwise legally required to make.

 

Enquiries to:

 

John O'Shea

IMI

Tel: +44 (0)121 717 3780

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSEUFSMEFSEFL
Date   Source Headline
8th Apr 20222:53 pmRNSDirector/PDMR Shareholding
1st Apr 202210:39 amRNSTotal Voting Rights
31st Mar 20224:04 pmRNSDirector/PDMR Shareholding
31st Mar 20229:17 amRNSHolding(s) in Company
30th Mar 20226:03 pmRNSDirector/PDMR Shareholding
30th Mar 20226:02 pmRNSDirector/PDMR Shareholding
30th Mar 20225:58 pmRNSDirector/PDMR Shareholding
30th Mar 20225:57 pmRNSDirector/PDMR Shareholding
30th Mar 20225:53 pmRNSDirector/PDMR Shareholding
30th Mar 20225:49 pmRNSDirector/PDMR Shareholding
30th Mar 20225:48 pmRNSDirector/PDMR Shareholding
25th Mar 20224:21 pmRNSAnnual Financial Report
22nd Mar 20225:32 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:31 pmRNSDirector/PDMR Shareholding
22nd Mar 20225:30 pmRNSDirector/PDMR Shareholding
9th Mar 20224:52 pmRNSDirector/PDMR Shareholding
9th Mar 20224:51 pmRNSDirector/PDMR Shareholding
9th Mar 20224:49 pmRNSDirector/PDMR Shareholding
8th Mar 20223:09 pmRNSHolding(s) in Company
7th Mar 20222:24 pmRNSDirector/PDMR Shareholding
1st Mar 20225:37 pmRNSDirector/PDMR Shareholding
1st Mar 202211:00 amRNSTotal Voting Rights
25th Feb 20227:00 amRNSPreliminary results, year ended 31 December 2021
10th Feb 202210:53 amRNSHolding(s) in Company
9th Feb 20225:20 pmRNSDirector/PDMR Shareholding
9th Feb 20225:19 pmRNSDirector/PDMR Shareholding
9th Feb 20225:15 pmRNSDirector/PDMR Shareholding
1st Feb 202211:25 amRNSTotal Voting Rights
25th Jan 20223:27 pmRNSHolding(s) in Company
12th Jan 20222:04 pmRNSDirector/PDMR Shareholding
12th Jan 20222:01 pmRNSDirector/PDMR Shareholding
12th Jan 20221:58 pmRNSDirector/PDMR Shareholding
12th Jan 20221:54 pmRNSDirector/PDMR Shareholding
4th Jan 20224:59 pmRNSBlock listing Interim Review
4th Jan 202211:55 amRNSTotal Voting Rights
20th Dec 20217:00 amRNSCompletion of Adaptas Solutions acquisition
15th Dec 20214:53 pmRNSDirector/PDMR Shareholding
15th Dec 20214:51 pmRNSDirector/PDMR Shareholding
15th Dec 20214:48 pmRNSDirector/PDMR Shareholding
15th Dec 20214:37 pmRNSDirector/PDMR Shareholding
1st Dec 20213:30 pmRNSTotal Voting Rights
23rd Nov 20216:14 pmRNSTransaction in Own Shares
22nd Nov 20216:22 pmRNSTransaction in Own Shares
19th Nov 20216:01 pmRNSTransaction in Own Shares
18th Nov 20216:04 pmRNSTransaction in Own Shares
17th Nov 20216:04 pmRNSTransaction in Own Shares
16th Nov 20216:03 pmRNSTransaction in Own Shares
15th Nov 20217:00 amRNSProposed acquisition of Adaptas Solutions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.